|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
It's almost comical how welcoming it is these days.
TheStreet Ratings team reiterated 3 stocks with a hold rating on Tuesday
Cramer says the market likes just about everything it sees, which is great news since there's a lot to like.
TheStreet's Jim Cramer said at these prices he isn't expecting J&J to buy the cancer drug company.
Trade-Ideas LLC identified Pharmacyclics (PCYC) as a new lifetime high candidate
Trade-Ideas LLC identified Pharmacyclics (PCYC) as a pre-market mover with heavy volume candidate
The much ballyhooed J.P. Morgan Healthcare Conference kicks off Monday in San Francisco. Here are capsule summaries of some of the expected story lines from presenting companies.
Trade-Ideas LLC identified Pharmacyclics (PCYC) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
Health care stocks have the highest relative strength of any sector, an indication that they are outperforming the broad market through rallies and corrections alike.
Bristol-Myers Squibb Company (NYSE:BMY), Pharmacyclics, Inc.
Trade-Ideas LLC identified Pharmacyclics (PCYC) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate
Those positions might not offer instant profits, but a measured approach should pay off.
Cramer prefers Intel over Advanced Micro Devices, thinks you should buy RR Donnelley but wants to hear more about Zillow's merger with Trulia before recommending it.
Now that the Fed has done the right thing on monetary policy, investors should stop worrying and start thinking about how to make more money, Cramer says.
These stocks rising on unusual volume are within range of triggering breakout trades.
Trade-Ideas LLC identified Pharmacyclics (PCYC) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Infinity and Abbvie will jointly develop and market duvelisib.
A month after Fed Chair Janet Yellen's comments, ETFs covering both groups are pushing towards new highs on strong fundamental backdrops.
Imbruvica will be an important part of the treatment landscape for blood cancers.
TheStreet highlights 3 stocks pushing the drugs industry lower today.
Often when above-average volume moves into an equity, it precedes a large spike in volatility.
Those levels may not end the bull market, but short-sellers are taking note.
Unusual volume can be a major signal that hedge funds and momentum traders are piling into a stock ahead of a catalyst.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.